Skip to content

Clinical trials

Hyperlipoproteinemia Type II trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20092
20112
20122
20152
20163
20172
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2
Novartis Pharmaceuticals2
Aegerion Pharmaceuticals, Inc.1
Cerenis Therapeutics, SA1
Dr. Reddy's Laboratories Limited1
Federico II University1
Heart Care Foundation1
Merck Sharp & Dohme LLC1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II17
Homozygous Familial Hypercholesterolemia7
Hypercholesterolemia7
Atherosclerosis2
Cardiovascular Diseases2
Genetic Diseases, Inborn2
Hyperlipidemias2
Aortic Valve Stenosis1
Coronary Artery Disease1
Dyslipidemias1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.